ClinicalTrials.gg
CompletedNCT03472261Updated Apr 16, 2020

Integrated Management of Pronation Deformity in Cerebral Palsy

A Phase 3 interventional study of Botulinum toxin type A and Upper extremity orthoses in Cerebral Palsy, sponsored by Kocaeli University. Completed at 1 site in Turkey. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2020-04-16.

Sponsored by Kocaeli University · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
2 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 327 studies in Cerebral Palsy with a site in Turkey — 43 open to participants now, 50 under way, none of them phase 3. Cerebral Palsy · Turkey.

Enrollment
81st of 189
35 · median 32
Started
2018
with 27 others
Phase 3
11 of 327
none open now
Registered
31st of 327
by date
Lead sponsor
8 of 327
Kocaeli University

Among the 327 studies in Cerebral Palsy with a site in Turkey, this one is the 81st largest by enrollment of the 189 interventional ones that give a count, is one of 28 that started in 2018, is one of 11 in phase 3, and was the 31st registered.

Cerebral Palsy

1,939 studies on the registry are indexed under Cerebral Palsy; 457 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

43 of the 327 studies in Cerebral Palsy with a site in Turkey are open now. Recruiting first, the newest first:

38 more — sign in →

All 43 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 269 Cerebral Palsy studies recruiting now, 27 (10%) set no upper age limit and 234 (87%) stop at 75 or younger; 254 take children under 18; 52 take healthy volunteers.

This study: 2 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 327 studies in Cerebral Palsy with a site in Turkey, or all of them as a file.
02

Study summary

Pronation deformity is a very common problem in children with cerebral palsy. This deformity is usually has neural and non-neural aspects. In this clinical trial the aim is to show the importance of combine treatment approach with pharmacological and non-pharmacological modalities. .

Read the detailed description

Spasticity is not only the most common motor disorder but also the main cause of slowly developing contractures in children with cerebral palsy. Pronation deformity which is a very common problem in children with cerebral palsy is primarily due to spasticity of the pronator muscles. Reduced strength and loss of control of the supinator muscles and soft tissue and joint contractures usually coexist with spasticity of pronator muscles. There is very limited information about how to treat this deformity in the current literature.

In this prospective, randomized, controlled clinical trial the aim is to show the effectiveness of twister, and home exercise program in an integrated approach with BoNT-A injections on spasticity, and passive range of motion (pROM) of children with CP having pronation deformity.

03

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • cerebral palsy
  • botulinum toxin-A
  • pronator deformity
04

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of cerebral palsy
  • MAS score of pronator muscles at least 2
  • Gross Motor Functional Classification Scale level of I-IV
  • Scheduled to receive botulinum toxin injections to pronator teres and/or -pronator quadratus muscles besides other spastic upper extremity muscles

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive or behavioural problems
  • Less than 40 degrees of available passive range of motion in pronation
  • Severe dystonia in the affected upper limb
  • Received orthopedic surgery to affected upper limb
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Experimental Group

    Patients treated by Botulinum toxin A and twister and specific home exercise program

    Drug: Botulinum toxin type A · Other: Upper extremity orthoses · Other: Home exercise program

  • Active comparator
    Conventional Therapy Group

    Patients treated by Botulinum toxin A and specific home exercise program

    Drug: Botulinum toxin type A · Other: Home exercise program

Interventions

  • Dysport

  • OtherUpper extremity orthoses

    Twister

  • OtherHome exercise program

    Specific exercises for pronation deformity

06

What researchers measure

Primary outcomes

  1. Mean change from baseline Modified Ashworth Scale (MAS)

    Tone measurement

    Time frame: Week 12

Secondary outcomes

  1. Mean change from baseline passive range of supination

    Range of motion measurement

    Time frame: Week 12

  2. Mean change from baseline angle of catch (XV3) Tardieu scale

    Spasticity measurement

    Time frame: Week 12

  3. Mean change from baseline active range of supination

    Active range of motion

    Time frame: Week 12

Other outcomes

  1. Assisting Hand Assessment (AHA)

    Bilateral hand use

    Time frame: Week 12

07

Study locations

1 site
  • Kocaeli University
    Kocaeli, 41050, Turkey
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2018 to primary completion in Mar 2020, 24 months.

Of 17 phase 3 interventional studies under Cerebral Palsy, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 33 and three quarters within 59. This study's 24 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 14, 2018
First posted
Mar 21, 2018
StartActual
Mar 26, 2018
Primary completionActual
Mar 30, 2020
CompletionActual
Mar 30, 2020
Last update
Apr 16, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 16, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03472261
Lead sponsor
Kocaeli University
Responsible party
Nigar Dursun (Professor, Kocaeli University) — Principal investigator
First posted
Mar 21, 2018
Start date
Mar 26, 2018
Primary completion
Mar 30, 2020
Completion
Mar 30, 2020
Last update
Apr 16, 2020

Study contacts

Melike Akarsu, MSc
principal investigator · Kocaeli University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion